Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome

NCT06256432 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatorenal Syndrome
Liver Cirrhosis
Acute Kidney Injury
Ascites Hepatic

Interventions

DRUG: Ambrisentan
DRUG: Terlipressin

Sponsor

Noorik Biopharmaceuticals AG